Pfizer set for top 10 spot in India as formal Wyeth merger agreed
This article was originally published in Scrip
Executive Summary
Almost five years after Pfizer announced its $68bn acquisition of Wyeth globally, the two companies' already operationally "harmonized" India arms have approved plans for a formal legal merger, rewarding shareholders with a pre-merger dividend payout and promising improved long-term value from the combined entity.